Clot lipids in ischaemic heart disease

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Hemostasis and Thrombosis

Background:

• Coronary artery disease (CAD) and acute myocardial infarction (AMI) are significant cardiovascular diseases.
• The role of lipid composition within blood clots in the pathogenesis of ischemic heart disease is not fully understood.

Purpose of the Study:

• To investigate the lipid composition of plasma, HDL, and clots in patients with CAD and AMI compared to healthy subjects.
• To determine the relationship between clot lipid content and coagulation parameters in ischemic heart disease.

Main Methods:

• Analysis of total phospholipids (PL) and neutral lipid classes in plasma and HDL.
• Determination of coagulation parameters.
• Quantification of lipids within clots formed from platelet-rich plasma.

Main Results:

• Plasma and HDL lipid profiles, along with main coagulation parameters, showed no significant differences between groups.
• A selective elevation of triglycerides (TG) bound to clots was observed in patients with ischemic heart disease (AMI and CAD).
• This suggests enhanced binding of TG-rich lipoproteins to clots, rather than passive trapping.

Conclusions:

• Elevated clot-bound triglycerides in ischemic heart disease patients indicate increased lipoprotein-clot interaction.
• These alterations in clot composition may increase clot volume and impede fibrinolysis.
• This finding has potential significance in the pathogenesis of ischemic heart disease.